• Walmark

  • Sector: pharmaceutical industry
  • Client: ATERNUS
  • Year: 2015
  • Deal value: confidential
  • COPRIN acted as exclusive financial advisor to ATERNUS and its shareholders, founders of WALMARK, in relation to disposal of their remaining 50% share on voting rights in WALMARK to the owner of other 50%, fund managed by Mid Europa Partners („MEP“), one of the largest western-type private equity funds focused on Central and Eastern Europe.
  • This second mandate from the same client follows successful assignment completed in December 2012, when first 50% was sold to MEP and de facto 50/50 joint venture with MEP was set up.
  • After almost three years of cooperation with MEP, founding shareholders of Walmark decided to pursue other investment and life opportunities and important transaction was completed after complex negotiations in mid-2015. More info to be found in press release here.